Dermapharm Holding SE
FSX:DMP.DE
30.8 (EUR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||
Current Assets: | |||||||||||
Cash & Cash Equivalents
| 158.724 | 149.918 | 160.319 | 120.623 | 114.98 | 212.81 | 6.286 | 3.816 | 2.791 | 11.645 | 4.665 |
Short Term Investments
| 0.783 | 11.44 | 11.742 | 1.037 | 1.056 | 1.101 | 0.4 | 0.03 | 0.029 | 0.12 | 0.12 |
Cash and Short Term Investments
| 158.724 | 161.358 | 172.061 | 121.66 | 116.036 | 213.911 | 6.686 | 3.816 | 2.791 | 11.645 | 4.665 |
Net Receivables
| 140.113 | 117.163 | 104.179 | 70.571 | 64.282 | 41.127 | 104.763 | 68.076 | 62.142 | 84.224 | 108.513 |
Inventory
| 320.758 | 251.822 | 240.535 | 203.264 | 172.167 | 115.56 | 81.106 | 84.582 | 76.912 | 71.146 | 67.516 |
Other Current Assets
| 10.901 | 3.604 | 2.447 | 4.557 | 0.456 | 0.64 | 0.315 | 0.485 | 0.259 | 1.523 | 1.208 |
Total Current Assets
| 630.496 | 533.947 | 519.222 | 400.052 | 352.941 | 371.238 | 192.87 | 156.959 | 142.104 | 168.538 | 181.902 |
Non-Current Assets: | |||||||||||
Property, Plant & Equipment, Net
| 330.77 | 225.673 | 222.287 | 199.619 | 132.585 | 80.874 | 56.036 | 53.357 | 53.406 | 56.547 | 57.352 |
Goodwill
| 578.521 | 271.319 | 264.73 | 266.268 | 202.244 | 54.621 | 24.583 | 17.033 | 16.444 | 21.553 | 26.743 |
Intangible Assets
| 544.86 | 305.043 | 294.841 | 297.342 | 293.03 | 189.934 | 133.404 | 70.025 | 67.966 | 71.713 | 70.315 |
Goodwill and Intangible Assets
| 1,123.381 | 576.362 | 559.571 | 563.61 | 495.274 | 244.555 | 157.987 | 87.058 | 84.41 | 93.266 | 97.058 |
Long Term Investments
| 75.345 | 65.414 | 94.147 | 60.079 | 63.014 | 6.773 | 7.72 | 14.077 | 16.689 | 11.174 | 13.073 |
Tax Assets
| 22.832 | 11.44 | 0 | 0 | 1.056 | 0.039 | 0.29 | 0.218 | 0.028 | 0.952 | 0.472 |
Other Non-Current Assets
| 0.681 | 0.001 | 11.742 | 1.037 | 0.001 | 1.102 | 0.4 | 0.03 | 0.029 | 0.12 | 0.12 |
Total Non-Current Assets
| 1,553.009 | 878.89 | 887.747 | 824.345 | 691.93 | 333.343 | 222.433 | 154.74 | 154.562 | 162.059 | 168.075 |
Total Assets
| 2,183.505 | 1,412.836 | 1,406.969 | 1,224.396 | 1,044.871 | 704.581 | 415.303 | 311.699 | 296.666 | 330.597 | 349.977 |
Liabilities & Equity: | |||||||||||
Current Liabilities: | |||||||||||
Account Payables
| 86.641 | 56.1 | 52.101 | 50.37 | 35.355 | 28.181 | 23.367 | 24.526 | 18.139 | 27.449 | 25.378 |
Short Term Debt
| 116.43 | 4.887 | 5.58 | 26.044 | 11.263 | 71.577 | 32.264 | 65.883 | 24.906 | 20.382 | 52.118 |
Tax Payables
| 81.818 | 110.749 | 60.194 | 14.562 | 13.344 | 27.45 | 5.945 | 7.85 | 3.808 | 5.434 | 1.531 |
Deferred Revenue
| 0.942 | 155.341 | 96.612 | 54.783 | 50.263 | 45.267 | 24.199 | 24.395 | 17.823 | 48.153 | 89.327 |
Other Current Liabilities
| 190.476 | 1.464 | 1.32 | 1.675 | 5.54 | 1.373 | 0.746 | 0.619 | 0.705 | 1.053 | 1.837 |
Total Current Liabilities
| 394.489 | 217.792 | 155.613 | 132.872 | 102.421 | 146.398 | 80.576 | 115.423 | 61.573 | 97.037 | 168.66 |
Non-Current Liabilities: | |||||||||||
Long Term Debt
| 950.705 | 511.561 | 574.721 | 580.759 | 543.347 | 232.743 | 222.483 | 96.896 | 151.073 | 161.53 | 100.831 |
Deferred Revenue Non-Current
| 11.685 | 9.204 | 9.456 | 145.014 | 75.66 | -137.437 | 17.509 | 23.714 | 26.13 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 135.217 | 50.518 | 36.056 | 29.948 | 27.038 | 4.452 | 11.026 | 3.365 | 0.191 | 0 | 0 |
Other Non-Current Liabilities
| 134.676 | 91.269 | 131.289 | 11.221 | 11.915 | 202.34 | 10.024 | 11.495 | 13.257 | 38.02 | 39.125 |
Total Non-Current Liabilities
| 1,232.283 | 662.552 | 751.522 | 766.942 | 657.96 | 302.098 | 261.042 | 135.47 | 190.651 | 199.55 | 139.956 |
Total Liabilities
| 1,626.772 | 880.344 | 907.135 | 899.814 | 760.381 | 448.496 | 341.618 | 250.893 | 252.224 | 296.587 | 308.616 |
Equity: | |||||||||||
Preferred Stock
| 0 | 0 | 0 | 9.746 | 7.012 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 53.84 | 53.84 | 53.84 | 53.84 | 53.84 | 53.84 | 0.12 | 1.342 | 1.342 | 1.342 | 1.342 |
Retained Earnings
| 367.223 | 355.357 | 337.954 | 177.082 | 139.067 | 100.993 | 25.669 | 56.274 | 39.457 | 28.616 | 33.911 |
Accumulated Other Comprehensive Income/Loss
| 17.354 | 21.605 | 4.732 | -9.746 | -7.012 | -90.65 | -50.644 | -45.052 | -41.515 | -40.226 | -39.204 |
Other Total Stockholders Equity
| 100.79 | 100.79 | 100.79 | 91.044 | 85.742 | 188.266 | 98.54 | 44.351 | 41.818 | 38.544 | 39.454 |
Total Shareholders Equity
| 539.207 | 531.592 | 497.316 | 321.966 | 278.649 | 252.449 | 73.685 | 56.915 | 41.102 | 28.276 | 35.503 |
Total Equity
| 545.048 | 532.492 | 499.834 | 324.582 | 284.49 | 256.085 | 73.685 | 60.806 | 44.442 | 34.01 | 41.361 |
Total Liabilities & Shareholders Equity
| 2,183.505 | 1,412.836 | 1,406.969 | 1,224.396 | 1,044.871 | 704.581 | 415.303 | 311.699 | 296.666 | 330.597 | 349.977 |